Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist
- PMID: 17943460
- DOI: 10.1007/s10689-007-9167-3
Genetic counseling and clinical management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations: perspective of a surgical oncologist
Abstract
Women with a family history of breast cancer who are diagnosed with breast cancer are often counseled to undergo prophylactic mastectomy as part of their treatment for breast cancer. The majority of such individuals make these decisions in haste and without appropriate genetic counseling or testing. Most of them when tested for BRCA or other established mutations find that they are not mutation carriers. In retrospect, this realization leads many to question the wisdom of their prophylactic surgery which is often associated with complications and quality of life problems which they never envisioned. We have designed an algorithm for the management of these patients which minimizes these lifelong problems.
Similar articles
-
Genetic counseling and management of newly diagnosed breast cancer patients at genetic risk for BRCA germline mutations.Breast J. 2006 May-Jun;12(3):280-1; author reply 282-4. doi: 10.1111/j.1075-122X.2006.00260.x. Breast J. 2006. PMID: 16684334 No abstract available.
-
Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation.Breast J. 2004 Nov-Dec;10(6):475-80. doi: 10.1111/j.1075-122X.2004.21543.x. Breast J. 2004. PMID: 15569201
-
Bilateral prophylactic mastectomy in BRCA mutation carriers: what surgeons need to know.Ann Ital Chir. 2019;90:1-2. Ann Ital Chir. 2019. PMID: 30872561
-
BRCA mutation testing in determining breast cancer therapy.Cancer J. 2011 Nov-Dec;17(6):492-9. doi: 10.1097/PPO.0b013e318238f579. Cancer J. 2011. PMID: 22157293 Free PMC article. Review.
-
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.JAMA. 2019 Aug 20;322(7):666-685. doi: 10.1001/jama.2019.8430. JAMA. 2019. PMID: 31429902
Cited by
-
Family history in breast cancer in São Luís, Maranhão, Brazil.BMC Res Notes. 2016 Mar 10;9:155. doi: 10.1186/s13104-015-1471-7. BMC Res Notes. 2016. PMID: 26966075 Free PMC article.
-
DNA-testing for BRCA1/2 prior to genetic counselling in patients with breast cancer: design of an intervention study, DNA-direct.BMC Womens Health. 2012 May 8;12:12. doi: 10.1186/1472-6874-12-12. BMC Womens Health. 2012. PMID: 22569005 Free PMC article.
-
Improving the management of people with a family history of breast cancer in primary care: before and after study of audit-based education.BMC Fam Pract. 2013 Jul 24;14:105. doi: 10.1186/1471-2296-14-105. BMC Fam Pract. 2013. PMID: 23879178 Free PMC article.
-
Randomized trial of proactive rapid genetic counseling versus usual care for newly diagnosed breast cancer patients.Breast Cancer Res Treat. 2018 Aug;170(3):517-524. doi: 10.1007/s10549-018-4773-3. Epub 2018 Apr 2. Breast Cancer Res Treat. 2018. PMID: 29611029 Free PMC article. Clinical Trial.
-
Hereditary diffuse gastric cancer: prophylactic surgical oncology implications.Surg Clin North Am. 2008 Aug;88(4):759-78, vi-vii. doi: 10.1016/j.suc.2008.04.006. Surg Clin North Am. 2008. PMID: 18672140 Free PMC article. Review.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical